NA
XBI icon

NewEdge Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

NewEdge Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.6M Sell
20,370
-549
-3% -$68.5K 0.01% 970
2025
Q4 		$2.55M Buy
20,919
+10,331
+98% +$1.18M 0.01% 953
2025
Q3 		$1.06M Buy
10,588
+751
+8% +$67.6K ﹤0.01% 1372
2025
Q2 		$816K Sell
9,837
-27,315
-74% -$2.18M ﹤0.01% 1404
2025
Q1 		$3.01M Buy
37,152
+1,490
+4% +$133K 0.02% 683
2024
Q4 		$3.21M Buy
35,662
+548
+2% +$53.1K 0.02% 643
2024
Q3 		$3.47M Buy
35,114
+340
+1% +$33.4K 0.02% 592
2024
Q2 		$3.22M Sell
34,774
-2,069
-6% -$186K 0.02% 580
2024
Q1 		$3.5M Buy
36,843
+2,137
+6% +$198K 0.03% 499
2023
Q4 		$3.1M Sell
34,706
-317
-0.9% -$23.5K 0.03% 500
2023
Q3 		$2.56M Sell
35,023
-1,411
-4% -$113K 0.03% 523
2023
Q2 		$3.03M Buy
36,434
+26,373
+262% +$2.21M 0.03% 452
2023
Q1 		$767K Buy
10,061
+657
+7% +$54.5K 0.01% 909
2022
Q4 		$454K Buy
9,404
+5,817
+162% +$471K 0.01% 826
2022
Q3 		$285K Buy
3,587
+15
+0.4% +$1.26K ﹤0.01% 1233
2022
Q2 		$265K Buy
+3,572
New +$268K ﹤0.01% 1263
2022
Q1 		– Sell
-2,834
Closed -$317K – 1668
2021
Q4 		$317K Buy
+2,834
New +$342K ﹤0.01% 1300

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NewEdge Advisors's XBI Position: Q1 2026 in Review

NewEdge Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 2.6% in Q1 2026, selling an estimated $68.5K and leaving 20,370 shares worth $2.6M. The position accounts for 0.01% of the portfolio, ranked #970.

NewEdge Advisors first reported a position in XBI in Q4 2021 and has held it in 17 quarters since. The position peaked at $3.5M in Q1 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • NewEdge Advisors held 20,370 shares of State Street SPDR S&P Biotech ETF worth $2.6M as of Q1 2026.
  • NewEdge Advisors sold 549 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $68.5K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of NewEdge Advisors's portfolio in Q1 2026, its #970 holding.
  • NewEdge Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 17 quarters since.
  • NewEdge Advisors's State Street SPDR S&P Biotech ETF position peaked at $3.5M in Q1 2024.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.